High Levels of Expression of p27KIP1 and Cyclin E in Invasive Primary Malignant Melanomas
- 1 December 1999
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 113 (6) , 1039-1046
- https://doi.org/10.1046/j.1523-1747.1999.00812.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cellsOncogene, 1999
- Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma: Inverse Correlation with Disease-Free SurvivalThe American Journal of Pathology, 1998
- Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progressionOncogene, 1997
- Cancer Cell CyclesScience, 1996
- Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescenceExperimental Gerontology, 1996
- Immunohistochemical expression of retinoblastoma protein in cutaneous melanomasBritish Journal of Dermatology, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Characterization of IIB‐MEL‐J: A New and Highly Heterogenous Human Melanoma Cell LinePigment Cell Research, 1989
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980